Crypto Stock Skyrockets 684% on ETH Purchase Plans

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.

While headlines focus on the same overhyped AI names, a bigger opportunity is taking shape — and it’s flying under the radar.

A new report reveals 9 AI companies with real U.S. operations, accelerating revenue, and deep AI integration. These aren’t speculative plays — they’re positioned to benefit from a massive shift in how and where AI is being built.

This free guide includes:

…plus 6 more names with major upside potential.

The early window on these opportunities may be closing — now’s the time to see what’s coming next.

[Get your FREE copy now]

Wall Street extended its bullish narrative on Monday, driven by easing global trade tensions, renewed hopes for Federal Reserve rate cuts, and optimism surrounding AI.

Home Depot is expanding its presence in the professional contractor market with a $4.3 billion acquisition of GMS, a distributor of building products.

This deal, executed through its SRS Distribution unit, reinforces Home Depot’s shift toward serving electricians, roofers, and other year-round trade professionals, a group it sees as more resilient than casual DIYers.

The strategy is to secure more recurring, high-volume business from professionals who remain resilient when mortgage rates rise.

This isn’t a one-off experiment. It builds on last year’s $18 billion buyout of SRS, now acting as the consolidation arm for Home Depot’s B2B ambitions.

Home Depot is doubling down on predictable, contractor-driven revenue streams.

As consumer home improvement demand softens, this move presents an opportunity to achieve steadier margins and longer project cycles.

The acquisition also blocks a competing bid from QXO, signaling that Home Depot is willing to protect its turf aggressively.

Anyone evaluating a position in HD should consider how this transforms the business from a consumer-focused retailer into a hybrid supply chain operator with control over key distribution layers.

For customers and vendors, it could mean faster delivery, better inventory alignment, and fewer middlemen.

GMS brings its own supplier relationships and logistics infrastructure, giving Home Depot more control from warehouse to job site.

Rivals may feel pressure to follow suit. With Lowe’s slower on the B2B uptake, and specialty distributors still fragmented, Home Depot is gaining a lead it likely plans to extend.

Bitcoin is breaking records. But behind the scenes, a different story is unfolding — one that could catch many investors off guard.

Altcoins are quietly staging their own rally:

→ 100%, 300%, even 1,000%+ moves in some cases
→ Inflow records from major institutions
→ Policy changes accelerating mainstream crypto adoption

A new report reveals how to navigate the current setup — and how to potentially position ahead of what could be a massive rotation into select altcoins.

This updated crypto guide includes:

✔ The signals behind explosive altcoin moves
✔ A simple approach to identifying pre-run momentum
✔ The #1 altcoin setup right now — revealed as a free bonus

Access to this complete research package is just $5.60, but only for the next 48 hours.

[Get instant access here]

Robinhood has launched a new trading product for European users that blends stock exposure with blockchain flexibility.

The platform introduced tokenized representations of U.S. stocks and ETFs, giving non-U.S. investors round-the-clock access to equity markets through a crypto-like interface. 

This move reflects a broader push by Robinhood to reshape how retail traders access traditional assets.

Rather than relying solely on conventional market hours or intermediaries, these tokens allow users to engage more freely and potentially more frequently with U.S. equities from abroad.

It’s a strategic shift that mirrors the rising international interest in American tech companies and the infrastructure that powers them.

For shareholders, this expansion into tokenized assets opens a new frontier. Robinhood is signaling that it's aiming to become a full-spectrum digital finance platform.

The market’s early reaction has been supportive, viewing this as a strong step in aligning product innovation with global retail demand.

For users in the EU, it’s a breakthrough in access and convenience.

By offering 24/5 trading and targeting eventual 24/7 availability, Robinhood is removing traditional barriers while hinting at what a crypto-integrated future might look like.

This could appeal to a new class of users who value speed, flexibility, and decentralized interfaces.

Competitors are also watching closely.

Other platforms have begun rolling out similar capabilities, but Robinhood’s established base and rapid execution could give it an edge as tokenization moves further into the financial mainstream.

Be the smartest person in the room by reading 1440! Dive into 1440, where 4.5 million Americans find their daily, fact-based news fix.

We navigate through 100+ sources to deliver a comprehensive roundup from every corner of the internet – politics, global events, business, and culture, all in a quick, 5-minute newsletter.

It's completely free and devoid of bias or political influence, ensuring you get the facts straight.

Subscribe to 1440 today.

AbbVie (NYSE: ABBV) is acquiring Capstan Therapeutics in a deal valued at up to $2.1 billion, reinforcing its strategy to dominate next-generation immunology.

The acquisition adds a promising early-stage CAR-T platform focused on reprogramming immune cells to target autoimmune conditions.

This is not just pipeline padding. AbbVie is building a post-Humira future by targeting durable therapies that go beyond symptom control.

Capstan’s approach utilizes lipid nanoparticles to deliver genetic instructions to T cells, providing a novel method for resetting immune behavior at its source.

For investors, the Capstan acquisition signals a clear evolution in AbbVie’s playbook.

The company is moving from protecting past blockbusters to pursuing high-impact innovation that can shape the next decade of immunology.

While Skyrizi and Rinvoq still drive strong revenue, AbbVie is now laying early bets on platforms that could revolutionize the treatment of autoimmune diseases from the ground up.

Anyone evaluating a new position in AbbVie should view this as a forward-leaning move, not a defensive one.

Capstan’s platform gives AbbVie optionality in a space where major players, such as Novartis and Bristol Myers, are already pushing hard. Instead of reacting to competition,

AbbVie is signaling it plans to lead.

The company is investing early, backing science with capital, and establishing control over delivery technology that could unlock new classes of durable treatments.

👉 Click here to get our pre-market report to your cell for free!

You’ll be first in line when the market starts moving.

BitMine Immersion Technologies Inc [BMNR] $33.45 (+684.17%)

BitMine Immersion soared over 500% after appointing crypto bull Tom Lee as chairman and announcing a $250 million ETH-focused treasury strategy backed by top investors like Pantera Capital and Kraken.

Artelo Biosciences Inc [ARTL] $13.27 (+95.72%)

Artelo jumped after announcing positive Phase 1 trial results showing its novel non-opioid pain therapy was safe and well-tolerated in humans.

FatPipe Inc [FATN] $9.84 (+26.15%)

FatPipe rallied on news of its inclusion in the Russell 3000E and Russell Microcap Indexes, boosting visibility and institutional demand.

Unicycive Therapeutics Inc [UNCY] $4.77 (-29.85%)

Unicycive plunged after receiving a Complete Response Letter from the FDA due to manufacturing deficiencies at a third-party vendor, delaying approval of its kidney disease drug.

Chemed Inc [CHE] $486.27 (-13.07%)

Chemed dropped after slashing its full-year guidance, citing a surprise Medicare revenue cap shortfall at its VITAS hospice business and weaker Roto-Rooter demand.

Cyngn Inc [CYN] $ 14.40 (-11.82%)

Cyngn shares plunged after pricing a $17.2 million direct offering at $7.50 per share, a sharp discount from recent trading levels above $15.

As we dive into Q2 2025, the stock market is buzzing with opportunities, and I’ve got the insider scoop just for you.

I’ve handpicked the Top Seven Stocks for this quarter, offering you a clear roadmap for growth as the year progresses.

Here’s what makes this guide indispensable:

This isn’t merely a list; it’s your chance to seize the market’s hottest opportunities before they pass you by.

[Get Your Free Guide Now]

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.